{"id":87935,"date":"2024-08-23T11:08:00","date_gmt":"2024-08-23T15:08:00","guid":{"rendered":"https:\/\/glgstagingsite.com\/network-surveys\/glg-network-survey-tracker-pharmaceutical-cdmos-ii\/"},"modified":"2025-05-13T11:39:58","modified_gmt":"2025-05-13T15:39:58","slug":"glg-network-survey-tracker-pharmaceutical-cdmos-ii","status":"publish","type":"network-surveys","link":"https:\/\/glginsights.com\/de\/network-surveys\/glg-network-survey-tracker-pharmaceutical-cdmos-ii\/","title":{"rendered":"GLG Network Survey Tracker: Pharmaceutical CDMOs II"},"content":{"rendered":"<p>For this Network Survey, GLG surveyed 90 pharma and biotech CDMO decision makers from US, Europe (UK, France, Germany, Italy, Spain) and APAC (China, Australia, Singapore and Korea). This is the second iteration in this tracker series.<\/p>\n<p><strong>What will you learn from this survey?<\/strong><\/p>\n<ul>\n<li>Respondents evaluated key players including large molecule CDMOs such as Lonza, Catalent, Samsung Biologics, and Wuxi Biologics, and trending players among small molecule CDMOs such as Siegfried, Syngene, Wuxi Apptec, and Piramal.<\/li>\n<li>The respondents also commented on their current CDMO outsourcing including the outsourcing proportion, type of products outsourced, distribution among geographies, and how this is expected to change in the future.<\/li>\n<li>Lastly, the survey looked into the factors for selecting a CDMO provider, likelihood of various types of projects to be outsourced to major CDMOs, performance of CDMOs on various criteria, as well as change in pricing and service quality in the industry over the last few years.<\/li>\n<\/ul>\n<p><strong>Examples of findings:<\/strong><\/p>\n<ul>\n<li>Over four-in-ten respondents declared to be currently using Lonza (42%) and Catalent (41%) as their CDMOs.<\/li>\n<li>Quality issues continue to be the main reason for changing CDMOs for over eight-in-ten (83%) respondents.<\/li>\n<li>Four-in-ten (40%) respondents selected small molecule API, reporting it to be the most outsourced product in July 2024.<\/li>\n<\/ul>\n<\/div>\n","protected":false},"featured_media":0,"template":"","practice-area":[1800],"class_list":["post-87935","network-surveys","type-network-surveys","status-publish","hentry","practice-area-consumer-goods-and-services"],"_links":{"self":[{"href":"https:\/\/glginsights.com\/de\/wp-json\/wp\/v2\/network-surveys\/87935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/glginsights.com\/de\/wp-json\/wp\/v2\/network-surveys"}],"about":[{"href":"https:\/\/glginsights.com\/de\/wp-json\/wp\/v2\/types\/network-surveys"}],"version-history":[{"count":0,"href":"https:\/\/glginsights.com\/de\/wp-json\/wp\/v2\/network-surveys\/87935\/revisions"}],"wp:attachment":[{"href":"https:\/\/glginsights.com\/de\/wp-json\/wp\/v2\/media?parent=87935"}],"wp:term":[{"taxonomy":"practice-area","embeddable":true,"href":"https:\/\/glginsights.com\/de\/wp-json\/wp\/v2\/practice-area?post=87935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}